Tabuk Pharmaceuticals Manufacturing Company:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tabuk Pharmaceuticals Manufacturing Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7559
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:サウジアラビア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group, is a drug company that develops, manufactures and markets branded generic pharmaceuticals and under-licensed products. The company offers products in various therapeutic areas including alimentary tract and metabolism, antineoplastic and immuno-modulators, blood and blood forming organs, cardiovascular system, systemic anti infective, dermatologicals, genito-urinary system and sex hormones, multivitamin, musculo skeletal, nervous system, parasitology and respiratory system, among others. It markets its products in Saudi Arabia and abroad. Tabuk is headquartered in Riyadh, Saudi Arabia.

Tabuk Pharmaceuticals Manufacturing Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tabuk Pharma Enters into Distribution Agreement with Renapharma 10
Tabuk Pharma Enters into Distribution Agreement with Genetic 11
Licensing Agreements 12
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 12
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 13
Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma 14
Tabuk Pharma Enters into Licensing Agreement with Aenova 15
Tabuk Pharma Enters into Licensing Agreement with Pfizer 16
Asset Transactions 17
Acino Pharma Acquires Three Products from Tabuk Pharma 17
Tabuk Pharmaceuticals Manufacturing Company – Key Competitors 18
Tabuk Pharmaceuticals Manufacturing Company – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Key Facts 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tabuk Pharmaceuticals Manufacturing Company, Deals By Therapy Area, 2012 to YTD 2018 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tabuk Pharma Enters into Distribution Agreement with Renapharma 10
Tabuk Pharma Enters into Distribution Agreement with Genetic 11
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 12
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 13
Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma 14
Tabuk Pharma Enters into Licensing Agreement with Aenova 15
Tabuk Pharma Enters into Licensing Agreement with Pfizer 16
Acino Pharma Acquires Three Products from Tabuk Pharma 17
Tabuk Pharmaceuticals Manufacturing Company, Key Competitors 18
Tabuk Pharmaceuticals Manufacturing Company, Other Locations 18

List of Figures
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tabuk Pharmaceuticals Manufacturing Company:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Compagnie Ivoirienne d’Electricite (CIEC):企業の財務・戦略的SWOT分析
    Summary Compagnie Ivoirienne d'Electricite (CIE), a subsidiary of Eranove, is a power company that provides power generation, transmission, and distribution services. The company offers exporting, importing and marketing of electricity. It provides operation and management of hydroelectric and therm …
  • GW Pharmaceuticals Plc (GWP):企業の財務・戦略的SWOT分析
    GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Essar Power Limited:企業の発電所・SWOT分析2018
    Essar Power Limited - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Serum Institute of India Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Serum Institute of India Ltd (Serum Institute) is a biotechnology company that manufactures and markets vaccines and immuno-biologicals. The company offers products such as bacterial vaccines, viral vaccines, recombinant and combination vaccines, polysaccharide conjugate vaccines, meningococ …
  • State Oil Company of the Azerbaijan Republic:石油・ガス:M&Aディール及び事業提携情報
    Summary State Oil Company of the Azerbaijan Republic (SOCAR) is an oil and gas exploration company. The company explores oil and gas fields; and produces, processes and transports oil, gas and gas condensate. It markets petroleum and petrochemical products in domestic and international markets and s …
  • Air Transport Services Group, Inc.:戦略・SWOT・企業財務分析
    Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Daigas Group:企業の戦略・SWOT・財務分析
    Daigas Group - Strategy, SWOT and Corporate Finance Report Summary Daigas Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • TravelCenters of America LLC:企業の戦略・SWOT・財務情報
    TravelCenters of America LLC - Strategy, SWOT and Corporate Finance Report Summary TravelCenters of America LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Advanced Enzyme Technologies Ltd:企業の戦略・SWOT・財務情報
    Advanced Enzyme Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Advanced Enzyme Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Xintela AB (XINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …
  • Bestway Holdings Limited:企業の戦略・SWOT・財務情報
    Bestway Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bestway Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Driver and Vehicle Standards Agency:企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • vTv Therapeutics Inc (VTVT):企業の財務・戦略的SWOT分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company’s pipeline product portfolio includes small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of huma …
  • Qualcomm Incorporated (QCOM):企業の財務・戦略的SWOT分析
    Qualcomm Incorporated (QCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Punjab National Bank:戦略・SWOT・企業財務分析
    Punjab National Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Discovery Communications, Inc.:企業の戦略・SWOT・財務分析
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Blue Cross and Blue Shield Association:企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology company that offers research and clinical development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products such as MGN1703, MGN1601, MGN1404, MGN1331 and MGN1333. It uses proprietary platform technologi …
  • T2 Biosystems Inc (TTOO):企業の製品パイプライン分析2018
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆